Irvine Medicaid providers billed $974,862 for COVID-19 care in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

In 2024, Medicaid providers in Irvine billed at least $974,862 for services identified by HCPCS codes specific to COVID-19, based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid, a public health insurance initiative operated by states and co-financed by state and federal governments, offers coverage to low-income individuals and families, the elderly, children, and those with disabilities. The program remains one of the largest segments of the U.S. health care system. Further information about its funding is available from the Commonwealth Fund.

Because Medicaid is taxpayer-funded, fluctuations in local billing indicate how public health resources are distributed in the area.

This analysis classified COVID-19–related services as those tied to HCPCS codes clearly marked or described as “COVID-19” or “coronavirus” in billing documentation. Therefore, only claims directly labeled as COVID-19 in these codes are reflected; broader pandemic care not listed under these codes is not included.

Comparatively, in 2024, San Jose recorded the highest Medicaid payments for COVID-19 services in California, totaling $5,601,479 in such claims.

On average, Medicaid payments per provider in Irvine for COVID-19–classified services equaled $97,486, which was nearly double California’s average of $52,976.

COVID-19–designated services significantly drove growth in Medicaid spending in Irvine during the pandemic phase.

Other claim categories under Medicaid saw total payments rise by $56,802,495 from 2020 to 2024, indicating a 273% surge.

Annual average Medicaid payments in the two years leading to the pandemic in Irvine amounted to $15,232,930.

The Centers for Medicare & Medicaid Services reported combined federal and state Medicaid costs climbing to about $871.7 billion in fiscal 2023, making up roughly 18% of all U.S. health spending. This represents a significant increase from approximately $613.5 billion in 2019.

The approximately 40% increase over several years is mainly attributed to higher enrollment counts and more frequent use of services during and following the pandemic.

Budget legislation under the Trump administration advanced substantial changes, such as reducing federal Medicaid expenditures and restructuring the program. The “One Big Beautiful Bill Act,” enacted in 2025, is set to cut federal Medicaid support by over $1 trillion in the coming decade and introduces measures including work requirements and elevated cost-sharing that could restrict access and adjust funding for particular groups. The measures will likely require states to shoulder more expenses while limiting federal expansion of the program, as it continues to aid millions of Americans.

Medicaid Payments in Irvine Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $974,862 -91% $78,582,653
2023 $10,862,513 -74.3% $72,735,721
2022 $42,347,428 94.9% $87,817,741
2021 $21,729,602 206.9% $70,239,430
2020 $7,081,339 N/A $27,886,634
2019 $0 N/A $18,219,109
2018 $0 N/A $12,246,751
Top COVID-19–Related HCPCS Codes in Irvine
HCPCS Code Description Medicaid Payments Claims
87635 COVID Specific $974,862 24,392

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

Details for this analysis were sourced from the U.S. Department of Health and Human Services Medicaid Provider Spending database, available here.



Related

Dave Min, U.S. Representative of California's 47th Congressional District

House bill proposes mandatory harassment reporting programs for major transit agencies

Rep. Dave Min introduced a bill in the House aimed at strengthening passenger harassment reporting procedures and data collection within public transit systems, seeking to address and better track incidents.

Jim Traficant, Chief of Staff of FDA

FDA cites Boscogen, Inc. in Irvine for 4 violations during April 21 inspection

The Food and Drug Administration inspected Boscogen, Inc. in Irvine on April 21, issuing four citations related to food composition, standards, labeling and econ, according to the FDA’s official website.

Sara Brenner, Principal Deputy Commissioner at FDA

FDA reviews Fina International, Inc. in Tustin during April 28 inspection

On April 28, the FDA conducted a foodborne biological hazard inspection at Fina International, Inc. in Tustin, according to information on the agency’s website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Central OC Times.